Free Trial
NASDAQ:JYNT

Joint (JYNT) Stock Price, News & Analysis

Joint logo
$8.64 -0.15 (-1.71%)
Closing price 04:00 PM Eastern
Extended Trading
$8.68 +0.04 (+0.52%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Joint Stock (NASDAQ:JYNT)

Advanced

Key Stats

Today's Range
$8.57
$8.95
50-Day Range
$8.17
$9.36
52-Week Range
$7.50
$13.47
Volume
64,112 shs
Average Volume
59,221 shs
Market Capitalization
$123.75 million
P/E Ratio
45.48
Dividend Yield
N/A
Price Target
$17.00
Consensus Rating
Hold

Company Overview

Joint Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
74th Percentile Overall Score

JYNT MarketRank™: 

Joint scored higher than 74% of companies evaluated by MarketBeat, and ranked 176th out of 856 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Joint has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 2 hold ratings, and 1 sell rating.

  • Upside Potential

    Joint has a consensus price target of $17.00, representing about 96.8% upside from its current price of $8.64.

  • Amount of Analyst Coverage

    Joint has only been the subject of 1 research reports in the past 90 days.

  • Read more about Joint's stock forecast and price target.
  • Earnings Growth

    Earnings for Joint are expected to grow by 38.71% in the coming year, from $0.31 to $0.43 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Joint is 45.48, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.55.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Joint is 45.48, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 29.03.

  • Price to Book Value per Share Ratio

    Joint has a P/B Ratio of 8.55. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Joint's valuation and earnings.
  • Short Interest

    There is no current short interest data available for JYNT.
  • Dividend Yield

    Joint does not currently pay a dividend.

  • Dividend Growth

    Joint does not have a long track record of dividend growth.

  • News Sentiment

    Joint has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Joint this week, compared to 3 articles on an average week.
  • MarketBeat Follows

    1 people have added Joint to their MarketBeat watchlist in the last 30 days.
  • Net Insider Buying

    Over the last three months, insiders have purchased a net $139,139.00 in company stock, which represents 0.1124% of the company's market cap.

  • Insider Buying vs. Insider Selling

    In the past three months, Joint insiders have bought more of their company's stock than they have sold. Specifically, they have bought $139,139.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    30.20% of the stock of Joint is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    76.88% of the stock of Joint is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Joint's insider trading history.
Receive JYNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Joint and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

JYNT Stock News Headlines

Nobody Understands Why Trump Is Invading Iran (here’s the answer)
Most investors are reacting to the Iran strikes without understanding the underlying motive driving the decision. Addison Wiggin, Founder of Grey Swan Investment Fraternity, says there is a hidden reason behind the bombing - and knowing it could change how you position your money right now.tc pixel
See More Headlines

JYNT Stock Analysis - Frequently Asked Questions

Joint's stock was trading at $8.72 at the start of the year. Since then, JYNT stock has decreased by 0.9% and is now trading at $8.64.

The Joint Corp. (NASDAQ:JYNT) released its quarterly earnings results on Thursday, March, 12th. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of $0.05 by $0.02. The business earned $15.17 million during the quarter, compared to analysts' expectations of $14.12 million. Joint had a net margin of 4.99% and a negative trailing twelve-month return on equity of 1.28%.
Read the conference call transcript
.

Joint's board initiated a stock repurchase plan on Thursday, June 5th 2025, which authorizes the company to buy back $5,000,000 in outstanding shares, according to EventVestor. This means that the company could purchase up to 2.7% of its shares through open market purchases. Shares buyback plans are often a sign that the company's board believes its shares are undervalued.

Joint (JYNT) raised $20 million in an initial public offering on Tuesday, November 11th 2014. The company issued 3,000,000 shares at $6.00-$7.00 per share. Roth Capital Partners and Feltl and Company served as the underwriters for the IPO and Sanders Morris Harris was co-manager.

Joint's top institutional shareholders include Skylands Capital LLC (6.24%), Bank of New York Mellon Corp (0.21%) and Strs Ohio (0.12%). Insiders that own company stock include Bandera Partners Llc and Christopher M Grandpre.
View institutional ownership trends
.

Shares of JYNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Joint investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
3/12/2026
Today
5/05/2026
Next Earnings (Estimated)
5/07/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - HMO
Sub-Industry
Trading
Current Symbol
NASDAQ:JYNT
CIK
1612630
Employees
320
Year Founded
1999

Price Target and Rating

High Price Target
$18.00
Low Price Target
$16.00
Potential Upside/Downside
+96.8%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.19
Trailing P/E Ratio
45.48
Forward P/E Ratio
27.87
P/E Growth
N/A
Net Income
$2.91 million
Net Margins
4.99%
Pretax Margin
-0.42%
Return on Equity
-1.28%
Return on Assets
-0.38%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.59
Quick Ratio
1.59

Sales & Book Value

Annual Sales
$54.90 million
Price / Sales
2.25
Cash Flow
$0.09 per share
Price / Cash Flow
91.50
Book Value
$1.01 per share
Price / Book
8.55

Miscellaneous

Outstanding Shares
14,323,000
Free Float
9,997,000
Market Cap
$123.75 million
Optionable
Optionable
Beta
1.11

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:JYNT) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners